| 8.14 Real-Time Quote | +0.085 / +1.06%Today’s Change | 1.55 Today|||52-Week Range 9.98 | +210.50% Year-to-Date |
The 7 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a +59.80% increase from the last price of 8.14.

The current consensus among 7 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




